ADCs in the Treatment of Breast Cancer and Gastric Cancer and Managing AEs Associated with ADCs

Sponsored in part by Daiichi Sankyo. Content independently developed by Oncology Nursing News®

A panel of experts in oncology review the use of antibody drug conjugates (ADCs) in breast and gastric cancers, defining optimal management of ADC-related adverse events.